Tuberculosis (Tuberculoses) Summary

Networked: 29301 relevant articles (1200 outcomes, 2429 trials/studies) for this Disease

Key Drugs and Agents for Tuberculosis

1. Isoniazid (Ftivazide) : 115 outcomes 232 studies in 2557 results : FDA 49 Generic
   
2. Vaccines : 110 outcomes 62 studies in 727 results : IBA
   
3. Rifampin (Rifampicin) : 95 outcomes 148 studies in 1794 results : FDA 13 Generic
   
4. Antigens : 80 outcomes 131 studies in 1892 results : IBA
   
5. Tuberculin (PPD) : 67 outcomes 184 studies in 2463 results : IBA
   
6. BCG Vaccine : 64 outcomes 32 studies in 353 results : FDA 1
   
7. DNA (Deoxyribonucleic Acid) : 54 outcomes 45 studies in 857 results : IBA
   
8. butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB) : 40 outcomes 74 studies in 981 results : IBA
   
9. Anti-Bacterial Agents (Antibiotics) : 33 outcomes 28 studies in 543 results : IBA
   
10. Pyrazinamide : 29 outcomes 56 studies in 540 results : FDA 3 Generic
    

Diseases Related to Tuberculosis

1. Infection
2. Pulmonary Tuberculosis
3. Leprosy (Hansen's Disease)
4. Acquired Immunodeficiency Syndrome (AIDS)
5. HIV Infections (HIV Infection)

Key Therapies for Tuberculosis

1. Drug Therapy (Chemotherapy) : 139 outcomes 236 studies in 2710 results
   
2. Chemoprevention : 21 outcomes 36 studies in 452 results
   
3. Directly Observed Therapy : 13 outcomes 23 studies in 252 results
   
4. Debridement : 9 outcomes 17 studies in 106 results
   
5. Immunotherapy : 9 outcomes 14 studies in 122 results